Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 19:4:7-11.
doi: 10.1016/j.sopen.2020.10.003. eCollection 2021 Apr.

Optimal hepatobiliary scintigraphy for gallbladder dyskinesia

Affiliations

Optimal hepatobiliary scintigraphy for gallbladder dyskinesia

K F Flick et al. Surg Open Sci. .

Abstract

Background: The accuracy of hepatobiliary scintigraphy to assess gallbladder function remains controversial. National supply shortages of pharmaceutical-grade cholecystokinin led to the use of an oral fatty meal to stimulate gallbladder contraction during hepatobiliary scintigraphy. The goal of this study was to compare the predictive indices of cholecystokinin and fatty meal ingestion for stimulation of gallbladder contraction.

Methods: Patients evaluated with hepatobiliary iminodiacetic acid scan from 2014 to 2017 were reviewed and grouped based on testing stimulant (fatty meal versus cholecystokinin). Patients who later underwent cholecystectomy were selected for analysis. Hepatobiliary iminodiacetic acid results were correlated with surgical pathology and postoperative resolution of symptoms. Two-way statistical analysis was performed.

Results: A total of 359 patients underwent hepatobiliary iminodiacetic acid scan followed by cholecystectomy for biliary dyskinesia. Patients who received fatty meal stimulant (n = 86) were compared to those that received cholecystokinin (n = 273). Mean gallbladder ejection fraction during hepatobiliary iminodiacetic acid was 38% and 44% for the cholecystokinin and fatty meal groups, respectively, P = .073. Predictive metrics were not statistically different between groups with regard to pathology, symptomatic improvement, or accuracy. Symptomatic resolution (cholecystokinin-hepatobiliary iminodiacetic acid 78%, fatty meal-hepatobiliary iminodiacetic acid 68%; P = 0.058) and specificity (cholecystokinin-hepatobiliary iminodiacetic acid 26%, fatty meal-hepatobiliary iminodiacetic acid 44%, P = 0.417) were comparable in both testing groups.

Conclusion: Stimulation of gallbladder contraction with a fatty meal during hepatobiliary iminodiacetic acid testing is a more affordable and reliable alternative to cholecystokinin for patients undergoing evaluation for gallbladder dysmotility.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Gallbladder EF% distribution with mean and 1 standard deviation represented. A logistic regression analysis was performed which indicated no significant difference in mean [SD] GBEF between CCK (38% [27]) and Ensure (44% [27]) after adjusting for age, gender, race, and diabetes, P = .073. Abbreviations: EF, ejection fraction; SD, standard deviation.

References

    1. Shaffer E. Acalculous biliary pain: new concepts for an old entity. Dig Liver Dis. 2003;35(Suppl. 3):S20–S25. - PubMed
    1. Whipple A.O. Surgical criteria for cholecystectomy. Bull N Y Acad Med. 1926;2(6):302–306. - PMC - PubMed
    1. Gunay A., Gurbuz A.K., Narin Y., Ozel A.M., Yazgan Y. Gallbladder and gastric motility in patients with idiopathic slow-transit constipation. South Med J. 2004;97(2):124–128. - PubMed
    1. Harvey R.F., Read A.E. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet (London, England) 1973;1(7793):1–3. - PubMed
    1. DiBaise J.K., Richmond B.K., Ziessman H.A., Everson G.T., Fanelli R.D., Maurer A.H. Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel. Clin Nucl Med. 2012;37(1):63–70. - PubMed

LinkOut - more resources